stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Clinical Trial for Stem Cell Cancer Treatment Approved

Posted by pamela@stemsave.com on Jun 26, 2013 12:19:48 PM

Mesenchymal stem cells Mesenchymal stem cells

Apceth, a leader in the development of stem cell treatments, has won approval for a Phase I/II multicenter clinical trial evaluating an autologous mesenchymal stem cell (MSC) therapy for gastrointestinal cancer. The treatment involves the utilization of the patient’s own stem cells to combat and destroy cancerous cells and is designed to enable highly localized treatments.

Apceth’s novel use of stem cells to treat cancer is indicative of the impact stem cell based treatments will have on medicine. Using the patient’s own [autologous] stem cells to treat a broad range of disease, trauma and injury represents the emerging gold standard in regenerative medicine.

Banking your own stem cells when they are young, vital, and proliferative is the best way to assure access to these emerging regenerative therapies. To learn how to bank your own valuable stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.

To view the full article, click here.

The future of Regenerative Medicine is now™

Topics: Gastrointestinal cancer, Phase III, stemsaveblog, clinical trials, stomach, Stemcells, autologousstemcells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all